中华医学科研管理杂志2024,Vol.37Issue(4) :323-329.DOI:10.3760/cma.j.cn113565-20240312-00074

医药领域新型研发机构运行管理机制探索——以翔安创新实验室为例

Exploration of operation and management mechanism of novel research and development institutions in medi-cine field:A case study of the Xiang An Biomedicine Laboratory

谢靖凡 何少贵 欧明展 姜薇 张楠 刘凡
中华医学科研管理杂志2024,Vol.37Issue(4) :323-329.DOI:10.3760/cma.j.cn113565-20240312-00074

医药领域新型研发机构运行管理机制探索——以翔安创新实验室为例

Exploration of operation and management mechanism of novel research and development institutions in medi-cine field:A case study of the Xiang An Biomedicine Laboratory

谢靖凡 1何少贵 1欧明展 2姜薇 1张楠 1刘凡3
扫码查看

作者信息

  • 1. 翔安创新实验室,厦门 361104
  • 2. 厦门大学 361102
  • 3. 翔安创新实验室,厦门 361104;厦门大学 361102
  • 折叠

摘要

目的 新型研发机构是新时期科技创新的重要战略力量.本文旨在通过对医药领域新型研发机构在建设和运行管理过程中所面临的问题进行分析,以期为其未来发展提供理论和实践指导.方法 根据翔安创新实验室的建设实践和国内外类似机构的建设经验,采用文献研究和案例分析法对新型研发机构的运行管理机制进行探索和分析.结果 医药领域新型研发机构建设过程中面临诸多问题,如政策支持存在盲区、对高层次人才吸引力有限、自我造血能力较弱、激励和评价体系不健全等,需要建立区别于传统研发机构的管理模式和运行体系.结论 医药领域新型研发机构应充分发挥体制优势,建立高效的管理和激励体系,构建适宜的人才队伍,强化有组织科研和科技成果转化.各级政府部门应提供一揽子政策支持,在建设初期给予稳定财政投入,并设计适合的评价体系.

Abstract

Objective Novel research and development institutions are crucial strategic forces for technological innovation in the new era.This article analyzed the problems faced by novel research and development institutions in medicine field during their construction and operation,and proposed solutions and countermeasure suggestions,aiming to provide theoretical and practical guidance for their future development.Methods The author summarized the construction experience of similar insti-tutions domestic and international through literature research and multiple case studies,and explored and analyzed the operation and management mechanisms of novel research and development institutions based on the practice of Xiang An Biomedicine La-boratory.Results The construction of novel research and development institutions in medicine field faced various problems,such as the existence of blind spots in policy support,limited attractiveness to high-level talents,weak self-renewal capabili-ties,and inadequate incentive and evaluation systems.It was necessary to establish a management model and operation system that were different from those of traditional research and development institutions.Conclusions Novel research and develop-ment institutions in the medical field should fully leverage their systemic advantages to establish efficient management and in-centive systems,build a suitable talent pool,and strengthen the transformation of scientific and technological achievements.Government departments at all levels should provide a comprehensive package of policy support,offer stable financial invest-ment during the initial construction phase,and design appropriate evaluation systems.

关键词

医药/新型研发机构/运行管理机制/科技创新

Key words

Medicine/New research and development institutions/Operation management mechanism/Technolog-ical innovation

引用本文复制引用

基金项目

国家自然科学基金科学部综合科技活动项目(82342001)

出版年

2024
中华医学科研管理杂志
中华医学会

中华医学科研管理杂志

CSTPCD
影响因子:0.515
ISSN:1006-1924
段落导航相关论文